We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

208 hedge funds and large institutions have $8.4B invested in BeOne Medicines Ltd in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% more ownership

Funds ownership: 3.52% → 3.77% (+0.25%)

7% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 69

5% less funds holding

Funds holding: 219 → 208 (-11)

18% less capital invested

Capital invested by funds: $10.3B → $8.4B (-$1.9B)

27% less funds holding in top 10

Funds holding in top 10: 11 → 8 (-3)

29% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 38

64% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $29.9M

Holders
208
Holders Change
-11
Holders Change %
-5.02%
% of All Funds
3.27%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.13%
New
27
Increased
64
Reduced
69
Closed
38
Calls
$10.8M
Puts
$29.9M
Net Calls
-$19.1M
Net Calls Change
-$38.7M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$163M
2
BlackRock
BlackRock
New York
+$37.5M
3
UBS Group
UBS Group
Switzerland
+$12.4M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$12.2M
5
Temasek Holdings
Temasek Holdings
Singapore
+$9.59M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$68M
2
Capital International Investors
Capital International Investors
California
-$62.2M
3
State Street
State Street
Massachusetts
-$59.1M
4
FFM
Fairmount Funds Management
Pennsylvania
-$51.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$50M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
176
Group One Trading
Illinois
$27.6K +$35.7K +155 New
Toronto Dominion Bank
177
Toronto Dominion Bank
Ontario, Canada
$22K – – –
Amundi
178
Amundi
France
$21.9K -$156K -678 -85%
QCG
179
Quadrant Capital Group
Ohio
$20K -$461 -2 -2%
Zurich Cantonal Bank
180
Zurich Cantonal Bank
Switzerland
$15.9K -$6.22K -27 -23%
HIA
181
Harbor Investment Advisory
Maryland
$13.7K – – –
Carson Wealth (CWM LLC)
182
Carson Wealth (CWM LLC)
Nebraska
$10K +$691 +3 +6%
PTC
183
Private Trust Company
Ohio
$9.81K -$3.69K -16 -23%
HI
184
Harbour Investments
Wisconsin
$7.67K – – –
EWA
185
EverSource Wealth Advisors
Alabama
$6.24K -$461 -2 -5%
BTI
186
Blue Trust Inc
Georgia
$5K -$33.9K -147 -87%
BG
187
Bollard Group
Massachusetts
$5K +$6.45K +28 New
LFG
188
Larson Financial Group
Missouri
$4.1K – – –
GWS
189
Glassman Wealth Services
Virginia
$3.92K – – –
TJHA
190
Thomas J. Herzfeld Advisors
Florida
$3.92K – – –
FFA
191
Farther Finance Advisors
California
$3.39K – – –
FRA
192
Front Row Advisors
California
$2K – – –
EBA
193
Eagle Bay Advisors
New York
$1.6K – – –
GRP
194
Global Retirement Partners
California
$1.43K – – –
SWM
195
Spire Wealth Management
Virginia
$1.43K – – –
VCM
196
Versant Capital Management
Arizona
$1.43K – – –
S
197
SignatureFD
Georgia
$1.25K -$461 -2 -22%
Northwestern Mutual Wealth Management
198
Northwestern Mutual Wealth Management
Wisconsin
$1.25K +$461 +2 +40%
JWA
199
JFS Wealth Advisors
Pennsylvania
$1.07K – – –
POIA
200
Pin Oak Investment Advisors
Texas
$1K +$1.61K +7 New
6 7
8
9 10

ONC Hedge Fund Activity: Q2 2023 in Review

208 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2023, worth a combined $8.4B — down 18% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of ONC and 27 opened new positions — a net loss of 11 holders — while 69 trimmed existing stakes and 64 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $163M. The largest seller was HHLR Advisors, cutting an estimated $68M.

  • 208 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $8.4B of BeOne Medicines Ltd stock for Q2 2023, down 18% quarter-over-quarter.
  • 27 funds opened new BeOne Medicines Ltd positions in Q2 2023 and 38 closed out, a net change of -11 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2023 was T. Rowe Price Associates, an estimated $163M added.
  • The largest BeOne Medicines Ltd seller in Q2 2023 was HHLR Advisors, an estimated $68M sold.

Based on aggregated 13F filings for Q2 2023.